All Pathways
UrologyEmergency

Urosepsis Management (EAU 2024 + SSC 2021)

Urosepsis Management (EAU 2024 + SSC 2021): Suspected Urosepsis → ⚠️ RECOGNIZE SEPSIS - TIME CRITICAL → SSC Hour-1 Bundle - START IMMEDIATELY → Empiric ...

Pathway Overview

14 steps

Algorithm Steps

14 total

  1. 01Start

    Suspected Urosepsis

    UTI with systemic inflammatory response

  2. 02Warning

    ⚠️ RECOGNIZE SEPSIS - TIME CRITICAL

    qSOFA: RR≥22, SBP≤100, altered mental status

    • qSOFA ≥2 = high mortality risk
    • SOFA score for organ dysfunction
    • Fever, rigors, flank pain, pyuria
    • Signs of shock: hypotension, tachycardia, mottling
    • Altered mental status = late sign
    • High index of suspicion in elderly/immunocompromised
  3. 03Action

    SSC Hour-1 Bundle - START IMMEDIATELY

    Do all within 1 hour of recognition

    • 1. Measure lactate (repeat if >2)
    • 2. Blood cultures BEFORE antibiotics
    • 3. Broad-spectrum IV antibiotics
    • 4. 30mL/kg crystalloid if hypotensive/lactate≥4
    • 5. Vasopressors if MAP<65 despite fluids
    • NEVER delay antibiotics for cultures
  4. 04Action

    Empiric Antibiotic Selection (EAU 2024)

    Broad coverage, adjust based on cultures

    • Community: Ceftriaxone 2g IV + Aminoglycoside
    • OR Piperacillin-tazobactam 4.5g IV q6h
    • Healthcare-associated: Add MRSA/Pseudomonas coverage
    • Carbapenem if ESBL risk or severe
    • Meropenem 1g IV q8h
    • De-escalate based on culture results
  5. 05Decision

    Obstructed Infected System?

    Critical decision - source control needed

  6. 06Warning

    ⚠️ URGENT SOURCE CONTROL

    Decompression saves lives (EAU Strong Rec)

    • Antibiotics CANNOT sterilize obstructed system
    • Must decompress to survive
    • Options: Nephrostomy tube OR Ureteral stent
    • Choice depends on patient stability and expertise
    • Do within hours, not days
    • Definitive stone treatment LATER
  7. 07Action

    Percutaneous Nephrostomy

    Often preferred in unstable patients

    • US or CT guided
    • Local anesthesia usually sufficient
    • Avoids general anesthesia
    • Direct decompression of renal pelvis
    • Send pus for culture
    • Higher success in dilated system
  8. 08Action

    ICU-Level Care

    For septic shock or organ dysfunction

    • Vasopressors: Norepinephrine first-line
    • Target MAP ≥65 mmHg
    • Central venous access
    • Arterial line for BP monitoring
    • Lactate clearance as marker
    • Consider stress-dose steroids if refractory
  9. 09Action

    Ongoing Monitoring

    Track response to treatment

    • Serial lactate (should decrease)
    • Urine output (target >0.5mL/kg/hr)
    • Mental status improvement
    • Temperature trending down
    • WBC and inflammatory markers
    • Culture results - narrow antibiotics
  10. 10Action

    Definitive Treatment

    After stabilization

    • Stone removal once sepsis resolved
    • Typically wait 2-4 weeks
    • Transition to oral antibiotics
    • Total duration: 7-14 days
    • Address underlying cause
    • Evaluate for structural abnormalities
  11. 11Outcome

    Outcomes

    Mortality 20-40% if delayed treatment

    • Early recognition + treatment: <10% mortality
    • Delayed decompression: 20-40% mortality
    • Key: antibiotics + source control FAST
    • Long-term: address stone/obstruction cause
  12. 12Action

    Retrograde Ureteral Stent

    Alternative decompression

    • Requires cystoscopy (brief GA/sedation)
    • May not pass if stone impacted
    • Internal drainage
    • Less invasive long-term
    • Consider if stable and experienced OR
  13. Path rejoins step 08Shared downstream outcome
  14. 13Action

    Non-Obstructed Urosepsis

    Antibiotics and supportive care

    • Continue IV antibiotics
    • Aggressive fluid resuscitation
    • ICU if hemodynamically unstable
    • Look for other sources (prostatitis, abscess)
    • Renal/perinephric abscess may need drainage
    • Emphysematous pyelonephritis high mortality
  15. Path rejoins step 08Shared downstream outcome
  16. 14Action

    Urgent Imaging

    Identify obstructed system

    • CT abdomen/pelvis (non-contrast OK for obstruction)
    • US if CT not immediately available
    • Look for: hydronephrosis, stone, abscess
    • Pyonephrosis = purulent obstructed system
    • Air in collecting system concerning
    • Do NOT delay source control for imaging
  17. Path rejoins step 05Shared downstream outcome

Guideline Source

EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not replace ICU-level sepsis management
  • Antibiotic choice depends on local resistance patterns
  • Complex cases require multidisciplinary input
  • Does not address pediatric urosepsis
  • Immunocompromised patients may present atypically

Contraindicated Populations

pediatric_complex

Applicable Regions

USEUUKAU

AU: Australian Sepsis Network guidelines align with SSC

EU: EAU 2024 primary guideline, SSC for sepsis principles

UK: NICE Sepsis guidelines + EAU concordant

US: SSC 2021 + IDSA guidelines for antibiotic selection

Version 1Next review: 2028-01-11

Frequently Asked Questions

What is the Urosepsis Management (EAU 2024 + SSC 2021)?

The Urosepsis Management (EAU 2024 + SSC 2021) is a emergency clinical algorithm for Urology. It provides a structured decision tree to guide clinical decision-making, based on EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021.

What guideline is the Urosepsis Management (EAU 2024 + SSC 2021) based on?

This algorithm is based on EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021 (DOI: 10.1016/j.eururo.2024.03.035).

What are the limitations of the Urosepsis Management (EAU 2024 + SSC 2021)?

Known limitations include: Does not replace ICU-level sepsis management; Antibiotic choice depends on local resistance patterns; Complex cases require multidisciplinary input; Does not address pediatric urosepsis; Immunocompromised patients may present atypically. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Urosepsis Management (EAU 2024 + SSC 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free